Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
This study has been terminated.
Study NCT00060996   Information provided by United Therapeutics
First Received: May 19, 2003   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Critical Limb Ischemia
Peripheral Vascular Disease
Foot Ulcers
Rest Leg Pain
Additional conditions recognized in this trial
Foot Ulcer
Ischemia
Peripheral Vascular Diseases
Vascular Diseases
More general conditions related to this trial
Cardiovascular Diseases
Foot Diseases
Leg Ulcer
Pathologic Processes
Skin Diseases
Skin Ulcer
Additional drug interventions recognized in this trial
Treprostinil
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
United Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services